Imaging modalities and optimized imaging protocols in pregnant patients with cancer.
Imaging modalities
Pregnancy
Protocols
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
06
11
2022
accepted:
02
01
2023
revised:
29
12
2022
medline:
2
5
2023
pubmed:
24
1
2023
entrez:
23
1
2023
Statut:
ppublish
Résumé
Medical imaging during pregnancy may be necessary to diagnose conditions that affect the outcome of the mother and fetus. Diagnosis and staging of cancer in pregnant women can be particularly challenging due to fear of inherent risk to the fetus, lack of standardized imaging protocols, and ethical challenges posed while choosing the best imaging option. Ultrasound and MRI, due to lack of ionizing radiation, are preferred over CT and nuclear imaging. The latter may be considered only if the benefits of imaging outweigh maternal and fetal risk without exceeding the cumulative established fetal radiation dose threshold. This article provides an overview of all currently available imaging options that can be used for imaging cancer during pregnancy to support the best possible maternal and fetal outcomes.
Identifiants
pubmed: 36688976
doi: 10.1007/s00261-023-03798-0
pii: 10.1007/s00261-023-03798-0
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1579-1589Informations de copyright
© 2023. Crown.
Références
Tirada N, Dreizin D, Khati N, et al. Imaging prentant and lactating patients. RadioGraphics 2015; 35:1751–1765 https://doi.org/10.1148/rg.2015150031
Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, O'Sullivan DE, Booth CM, Sullivan R, Aggarwal A. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020 Nov 4;371:m4087. doi: https://doi.org/10.1136/bmj.m4087 . PMID: 33148535; PMCID: PMC7610021.
Khazzaka A, Rassy E, Sleiman Z, Boussios S, Pavlidis N. Systematic review of fetal and placental metastases among pregnant patients with cancer. Cancer Treat Rev. 2022 Mar; 104:102356. doi: https://doi.org/10.1016/j.ctrv.2022.102356 . Epub 2022 Feb 11. PMID: 35182890.
Wolters V, Heimovaara J, Maggen C, Cardonick E, Boere I, Lenaerts L, Amant F. Management of pregnancy in women with cancer. Int J Gynecol Cancer. 2021 Mar;31(3):314-322. doi: https://doi.org/10.1136/ijgc-2020-001776 . PMID: 33649001; PMCID: PMC7925815.
doi: 10.1136/ijgc-2020-001776.PMID:33649001;PMCID:PMC7925815
pubmed: 33649001
pmcid: 7925815
Kanishka Karunaratne, Samanthi Premaratne, Chintana Hapuachchige, Himali Ihalagama, Counselling pregnant women with cancer,Best Practice & Research Clinical Obstetrics & Gynaecology, Volume 33, 2016, Pages 117–123, ISSN 1521–6934.
Hobbs, Jason & Goldstein, Noah & Lind, Kimberly & Elder, Deirdre & Dodd, Gerald & Borgstede, James. (2017). Physician Knowledge of Radiation Exposure and Risk in Medical Imaging. Journal of the American College of Radiology. 15. https://doi.org/10.1016/j.jacr.2017.08.034 .
ACR-SPR Practice Guideline Parameter for Imaging Pregnant of Potentially Pregnant Adolescents and Women with Ionizing Radiation (2018) ( https://www.acr.org/-/media/ACR/Files/Practice-Parameters/Pregnant-Pts.pdf )
Huda W. Radiation risks: what is to be done? AJR Am J Roentgenol. 2015 Jan;204(1):124-7. doi: https://doi.org/10.2214/AJR.14.12834 . PMID: 25539247.
doi: 10.2214/AJR.14.12834
pubmed: 25539247
American College of Radiology. Administration of contrast media to pregnant or potentially pregnant patients. In: ACR manual on contrast media. Version 10.3. Reston (VA): ACR; 2022. p. 102 -107.
Wieseler KM, Bhargava P, Kanal KM, et al. Imaging in pregnant patients: Examination appropriateness. RadioGraphics 2010;30(5):1215–123 ( https://doi.org/10.1148/rg.305105034 )
Copel J, El-SayedY, Heine RP, et al. Guidelines for diagnostic imaging during pregnancy and lactation. Committee Opinion No. 723. American College of Obstetricians andGynecologists. Obstet Gynecol 2017;130: e210–6
Vandecaveye V, Amant F, Lecouvet F, et al Imaging modalities in pregnant cancer patients International Journal of Gynecologic Cancer 2021;31:423–431.
Torloni MR, Vedmedovska N, Merialdi M, Betrán AP, Allen T, González R, Platt LD; ISUOG-WHO Fetal Growth Study Group. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis. Ultrasound Obstet Gynecol. 2009 May;33(5):599–608. doi: https://doi.org/10.1002/uog.6328 . PMID: 19291813.
Ciet P, Litmanovich DE. MR safety issues particular to women. Magn Reson Imaging Clin N Am. 2015; 23:59–67. doi: https://doi.org/10.1016/j.mric.2014.09.002 .
doi: 10.1016/j.mric.2014.09.002
pubmed: 25476674
Woitek R, Prayer D, Hojreh A, Helbich T. Radiological staging in pregnant patients with cancer. ESMO Open. 2016;1:e000017. doi: https://doi.org/10.1136/esmoopen-2015-000017
Gui B, Cambi F, Micco M, Sbarra M, Petta F, Autorino R, De Vincenzo R, Valentini V, Scambia G, Manfredi R. MRI in pregnant patients with suspected abdominal and pelvic cancer: a practical guide for radiologists. Diagn Interv Radiol. 2020 May;26(3):183-192. doi: https://doi.org/10.5152/dir.2019.19343 . PMID: 32071031; PMCID: PMC7239363.
doi: 10.5152/dir.2019.19343
pubmed: 32071031
pmcid: 7239363
American Academy of Pediatrics Committee on Environmental Health. Noise: a hazard for the fetus and newborn. Pediatrics. 1997; 100:724–727. doi: https://doi.org/10.1542/peds.100.4.724 .
doi: 10.1542/peds.100.4.724
Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL (2016) Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. Journal of the American Medical Association. JAMA. 316(9):952–961 https://doi.org/10.1001/jama.2016.12126
Bird ST, Gelperin K, Sahin L, et al. First-Trimester Exposure to Gadolinium-basedContrast Agents: A Utilization Study of 4.6 million U.S. Pregnancies. Obstetric Imaging 2019; 293(1):193–200
FDA Drug Safety Communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-gadolinium-based-contrast-agents-gbcas-are-retained-body update 12/19/2017 and initial 5/22/2017.
Han SN, Amant F , Michielsen K , et al . Feasibility of whole-body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study. Eur Radiol 2018; 28:1862–74.doi: https://doi.org/10.1007/s00330-017-5126-z ( http://www.ncbi.nlm.nih.gov/pubmed/29218610 )
Peccatori FA, Codacci-Pisanelli G, Del Grande M, et al. Whole body MRI for systemic staging of breast cancer in pregnant women. The Breast 2017;35: 177–181. ( https://doi.org/10.1016/j.breast.2017.07.014 )
Godinho MV, Lopes FPPL, Costa FM. Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer. Cancer Manag Res. 2018 Dec 6;10:6743-6756. doi: https://doi.org/10.2147/CMAR.S167924 .
doi: 10.2147/CMAR.S167924
Wiech D, Peix S, Predel D, et al. Whole body MRI for Breast Cancer Staging: The roles of the Field Strength and Gadolinium Contrast Agents in Focus. Madridge J Oncogenesis. 2018; 2(1): 35-40. doi: https://doi.org/10.18689/mjo-1000106
doi: 10.18689/mjo-1000106
Mahajan A, Santhosh Kumar G V, Vaidya T, Thakur M, Desai S. Potential role of whole-body diffusion magnetic resonance imaging in tumor staging for pregnant patients with cancer. Indian J Cancer 2018; 55:417-8.
doi: 10.4103/ijc.IJC_244_18
pubmed: 30829283
Donners, R., Yiin, R.S.Z., Blackledge, M. et al. Whole-body diffusion-weighted MRI of normal lymph nodes: prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort. Cancer Imaging 21, 64 (2021). ( https://doi.org/10.1186/s40644-021-00432-4 )
Center for disease control and prevention. Radiation and Pregnancy: A fact sheet for clinicians. ( https://www.cdc.gov/nceh/radiation/emergencies/prenatalphysician.htm . Accessed 12/2/21)
McCollough CH, Schueler BA, Atwell TD, et al. Radiation exposure and pregnancy: When should we be concerned? Radiographics. 2007; 27:909–917; discussion 917–908.
Yousefzadeh DK, Ward MB, Reft C. Internal barium shielding to minimize fetal irradiation in spiral chest CT: a phantom simulation experiment. Radiology 2006; 239:751–8.
doi: 10.1148/radiol.2393042198
pubmed: 16714459
ACR manual on contrast media. ( https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf )
Niemann T, Nicolas G, Roser HW, Müller-Brand J, Bongartz G. Imaging for suspected pulmonary embolism in pregnancy-what about the fetal dose? A comprehensive review of the literature. Insights Imaging. 2010 Nov;1(5–6):361–372. doi: https://doi.org/10.1007/s13244-010-0043-6 . Epub 2010 Oct 2. PMID: 22347929; PMCID: PMC3259315.
International Atomic Energy Agency. Radiation protection of pregnant women in nuclear medicine. ( https://www.iaea.org/resources/rpop/health-professionals/nuclear-medicine/pregnant-women )
AlmuhaidebA, Papathanasiou N, Bomanji J. 18F-FDG PET/CT imaging in oncology. Ann Saudi Med. 2011;31(1):3–13. doi: https://doi.org/10.4103/0256-4947.75771
Takalkar AM, Khandelwal A, Lokitz S, et al. 18F-FDG PET in pregnancy and fetal radiation dose estimates. J Nucl Med 2011; 52:1035–40.
doi: 10.2967/jnumed.110.085381
pubmed: 21680687
Zanotti-Fregonara P, Jan S, Taieb D, et al. Absorbed 18F-FDG dose to the fetus during early pregnancy. J Nucl Med, 2010;51:803-805.
doi: 10.2967/jnumed.109.071878
pubmed: 20395321
Hsieh TC, MD, Wu YC, Sun SS, et al. FDG PET-CT of a Late-term Pregnant Woman with Breast Cancer. Clin Nucl Med, 2012;37: 489–491 ( http://www.ncbi.nlm.nih.gov/pubmed/22475901 )
Paolo Zanotti-Fregonara, Richard Laforest, and Jerold W. Wallis Fetal Radiation Dose from 18F-FDG in Pregnant Patients Imaged with PET, PET/CT, and PET/MR J Nucl Med 2015 56:1218–1222 published ahead of print June 18, 2015 https://doi.org/10.2967/jnumed.115.157032
Committee Opinion No 2017 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation Obstet Gynecol. 130 4 e210 e216 doi https://doi.org/10.1097/AOG.0000000000002355 . Erratum in: Obstet Gynecol. 2018 Sep;132(3):786. PMID: 28937575
Mitchell KB, Flemming MM, Anderson PO, et al. ABM Clinical Protocol #31: Radiology and Nuclear Medicine Studies in Lactating Women. Breastfeeding Medicine 2019; 14(5):290–294 (https://www.liebertpub.com/doi/ https://doi.org/10.1089/bfm.2019.29128.kbm )
Expert Panel on Breast Imaging: diFlorio-Alexander RM, Slanetz PJ, Moy L, Baron P, Didwania AD, Heller SL, Holbrook AI, Lewin AA, Lourenco AP, Mehta TS, Niell BL, Stuckey AR, Tuscano DS, Vincoff NS, Weinstein SP, Newell MS. ACR Appropriateness Criteria® Breast Imaging of Pregnant and Lactating Women. J Am Coll Radiol. 2018 Nov;15(11S): S263-S275. doi: https://doi.org/10.1016/j.jacr.2018.09.013 . PMID: 30392595.
NCCN Clinical Practice Guidelines in Oncology. Breast Cancer Screening and Diagnosis. Version 1.2016. ( https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf Accessed March 30,20180)